| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.05e-07 | 109 | 128 | 8 | GO:0042626 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.88e-07 | 49 | 128 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF1A KIF26A ABCB5 ABCB6 CHD7 ABCB1 ABCB4 ABCB8 HELZ2 CHD6 ABCG5 DYNC1H1 VCP | 5.28e-06 | 441 | 128 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF1A KIF26A TMEM94 ABCB5 ABCB6 CHD7 ABCB1 ABCB4 ATP6V0A4 ABCB8 HELZ2 CHD6 ABCG5 DYNC1H1 VCP | 9.37e-06 | 614 | 128 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.96e-05 | 178 | 128 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 4.09e-05 | 11 | 128 | 3 | GO:0004983 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 1.22e-04 | 3 | 128 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 1.36e-04 | 16 | 128 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.42e-04 | 123 | 128 | 6 | GO:0030165 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 2.43e-04 | 4 | 128 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | BAT3 complex binding | 2.43e-04 | 4 | 128 | 2 | GO:1904288 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 2.43e-04 | 4 | 128 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC29A3 TMEM94 ABCB5 ABCB6 ABCB1 ABCB4 SLC12A4 CLCN6 ATP6V0A4 ABCB8 ABCG5 | 2.55e-04 | 477 | 128 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 4.03e-04 | 5 | 128 | 2 | GO:0070915 | |
| GeneOntologyMolecularFunction | peptide YY receptor activity | 4.03e-04 | 5 | 128 | 2 | GO:0001601 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF1A KIF26A ABCB5 ABCB6 CHD7 GFM2 ABCB1 ABCB4 ABCB8 HELZ2 CHD6 ABCG5 DYNC1H1 VCP | 4.54e-04 | 775 | 128 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF1A KIF26A ABCB5 ABCB6 CHD7 GFM2 ABCB1 ABCB4 ABCB8 HELZ2 CHD6 ABCG5 DYNC1H1 VCP | 9.85e-04 | 839 | 128 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF1A KIF26A ABCB5 ABCB6 CHD7 GFM2 ABCB1 ABCB4 ABCB8 HELZ2 CHD6 ABCG5 DYNC1H1 VCP | 9.97e-04 | 840 | 128 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF1A KIF26A ABCB5 ABCB6 CHD7 GFM2 ABCB1 ABCB4 ABCB8 HELZ2 CHD6 ABCG5 DYNC1H1 VCP | 9.97e-04 | 840 | 128 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.11e-03 | 8 | 128 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC29A3 TSPOAP1 TMEM94 ABCB5 ABCB6 GRIK5 CACHD1 PKD1L2 PKDREJ ABCB1 ABCB4 SLC12A4 CLCN6 ATP6V0A4 ABCB8 PLP2 ABCG5 | 1.43e-03 | 1180 | 128 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC29A3 TSPOAP1 TMEM94 ABCB5 ABCB6 GRIK5 CACHD1 PKD1L2 PKDREJ ABCB1 ABCB4 SLC12A4 CLCN6 CIDEC ATP6V0A4 ABCB8 PLP2 ABCG5 | 1.46e-03 | 1289 | 128 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.70e-03 | 37 | 128 | 3 | GO:0045505 | |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 4.22e-06 | 6 | 126 | 3 | GO:0043190 | |
| HumanPheno | Ankle clonus | 1.95e-06 | 60 | 52 | 7 | HP:0011448 | |
| HumanPheno | Abnormal ankle physiology | 6.76e-06 | 72 | 52 | 7 | HP:0034674 | |
| HumanPheno | Clonus | 4.01e-05 | 129 | 52 | 8 | HP:0002169 | |
| MousePheno | globular heart | 9.52e-07 | 11 | 105 | 4 | MP:0031511 | |
| Domain | ABC_membrane | 4.76e-07 | 24 | 125 | 5 | PF00664 | |
| Domain | AAA | 5.36e-07 | 144 | 125 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 5.36e-07 | 144 | 125 | 9 | IPR003593 | |
| Domain | ABC_tran | 7.77e-07 | 48 | 125 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.77e-07 | 48 | 125 | 6 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 8.80e-07 | 49 | 125 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 9.95e-07 | 50 | 125 | 6 | IPR003439 | |
| Domain | ABC_TM1F | 1.08e-06 | 28 | 125 | 5 | PS50929 | |
| Domain | ABC1_TM_dom | 1.08e-06 | 28 | 125 | 5 | IPR011527 | |
| Domain | ABC_transporter_CS | 8.64e-06 | 42 | 125 | 5 | IPR017871 | |
| Domain | ARM-type_fold | RALGAPA1 CLASP1 NOC2L NBEA TSC2 HUWE1 MEI1 NF1 PDS5A ATM HTT | 1.76e-05 | 339 | 125 | 11 | IPR016024 |
| Domain | NPY_rcpt | 2.39e-05 | 9 | 125 | 3 | IPR000611 | |
| Domain | NPY4_rcpt | 4.44e-05 | 2 | 125 | 2 | IPR001933 | |
| Domain | LPA_rcpt | 1.33e-04 | 3 | 125 | 2 | IPR004065 | |
| Domain | VPS13 | 1.33e-04 | 3 | 125 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.33e-04 | 3 | 125 | 2 | PF16910 | |
| Domain | VPS13 | 1.33e-04 | 3 | 125 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.33e-04 | 3 | 125 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.33e-04 | 3 | 125 | 2 | IPR031642 | |
| Domain | P-loop_NTPase | NWD1 KIF1A KIF26A ABCB5 ABCB6 CHD7 GFM2 ABCB1 ABCB4 ABCB8 HELZ2 DLG1 CHD6 ABCG5 DYNC1H1 VCP | 1.72e-04 | 848 | 125 | 16 | IPR027417 |
| Domain | SHR-BD | 2.64e-04 | 4 | 125 | 2 | IPR009543 | |
| Domain | VPS13_C | 2.64e-04 | 4 | 125 | 2 | PF16909 | |
| Domain | REJ | 2.64e-04 | 4 | 125 | 2 | PS51111 | |
| Domain | VPS13_C | 2.64e-04 | 4 | 125 | 2 | IPR031645 | |
| Domain | REJ_dom | 2.64e-04 | 4 | 125 | 2 | IPR014010 | |
| Domain | SHR-BD | 2.64e-04 | 4 | 125 | 2 | PF06650 | |
| Domain | Autophagy-rel_C | 4.39e-04 | 5 | 125 | 2 | IPR015412 | |
| Domain | ATG_C | 4.39e-04 | 5 | 125 | 2 | PF09333 | |
| Domain | PKD_2 | 4.39e-04 | 5 | 125 | 2 | IPR003915 | |
| Domain | ARM-like | 4.71e-04 | 270 | 125 | 8 | IPR011989 | |
| Domain | - | NWD1 ABCB5 ABCB6 CHD7 GFM2 ABCB1 ABCB4 ABCB8 HELZ2 DLG1 CHD6 ABCG5 DYNC1H1 VCP | 4.73e-04 | 746 | 125 | 14 | 3.40.50.300 |
| Domain | BRK | 6.55e-04 | 6 | 125 | 2 | SM00592 | |
| Domain | BRK_domain | 6.55e-04 | 6 | 125 | 2 | IPR006576 | |
| Domain | PKD/REJ-like | 6.55e-04 | 6 | 125 | 2 | IPR002859 | |
| Domain | REJ | 6.55e-04 | 6 | 125 | 2 | PF02010 | |
| Domain | BRK | 6.55e-04 | 6 | 125 | 2 | PF07533 | |
| Domain | Integrin_B_tail | 9.13e-04 | 7 | 125 | 2 | SM01242 | |
| Domain | Integrin_bsu_tail | 9.13e-04 | 7 | 125 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 9.13e-04 | 7 | 125 | 2 | PF07965 | |
| Domain | Chorein_N | 1.21e-03 | 8 | 125 | 2 | PF12624 | |
| Domain | INB | 1.21e-03 | 8 | 125 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 1.21e-03 | 8 | 125 | 2 | IPR002369 | |
| Domain | VPS13_N | 1.21e-03 | 8 | 125 | 2 | IPR026854 | |
| Domain | Integrin_beta | 1.21e-03 | 8 | 125 | 2 | PF00362 | |
| Domain | Integrin_bsu | 1.55e-03 | 9 | 125 | 2 | IPR015812 | |
| Domain | INTEGRIN_BETA | 1.55e-03 | 9 | 125 | 2 | PS00243 | |
| Domain | PSI_integrin | 1.55e-03 | 9 | 125 | 2 | PF17205 | |
| Domain | Integin_beta_N | 1.55e-03 | 9 | 125 | 2 | IPR033760 | |
| Domain | Rap_GAP | 1.93e-03 | 10 | 125 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 2.35e-03 | 11 | 125 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.35e-03 | 11 | 125 | 2 | PS50085 | |
| Domain | PKD_channel | 2.35e-03 | 11 | 125 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 2.35e-03 | 11 | 125 | 2 | IPR013122 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.55e-07 | 44 | 91 | 6 | M11911 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.40e-06 | 99 | 91 | 7 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.43e-06 | 103 | 91 | 7 | M758 | |
| Pubmed | Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. | 5.10e-08 | 3 | 130 | 3 | 8643460 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 9542318 | ||
| Pubmed | Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP. | 2.04e-07 | 4 | 130 | 3 | 20126661 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKRD13D EPPK1 KIF26A TMEM94 LAMA5 TSC2 HUWE1 ZZEF1 ITGB4 CCDC88C C2CD3 SLC12A4 TMEM268 HELZ2 C19orf44 DYNC1H1 HTT | 8.47e-07 | 1105 | 130 | 17 | 35748872 |
| Pubmed | 1.48e-06 | 288 | 130 | 9 | 23383273 | ||
| Pubmed | 1.87e-06 | 153 | 130 | 7 | 10718198 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | FAM234A SLC29A3 DSC3 CLASP1 VPS45 HUWE1 LPAR1 CEMIP2 NF1 SLC12A4 ABCB8 VPS13A DLG1 PDS5A ATM PLP2 | 2.36e-06 | 1061 | 130 | 16 | 33845483 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KIF1A VPS13C NBEA TSC2 GRIK5 HUWE1 ZZEF1 ECT2 VPS13A PDS5A CHD6 ATM DYNC1H1 | 4.16e-06 | 736 | 130 | 13 | 29676528 |
| Pubmed | 4.22e-06 | 9 | 130 | 3 | 28180282 | ||
| Pubmed | AARS1 EPPK1 KIF1A NOC2L CHD7 HUWE1 NF1 HELZ2 PDS5A ATM DYNC1H1 VCP | 6.67e-06 | 653 | 130 | 12 | 22586326 | |
| Pubmed | Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids. | 1.10e-05 | 12 | 130 | 3 | 10090148 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | AMFR AARS1 FAM234A KIF1A NOC2L PNO1 TSC2 CACHD1 HUWE1 RTN2 CCNB2 PDS5A DYNC1H1 VCP | 1.24e-05 | 942 | 130 | 14 | 31073040 |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 10488067 | ||
| Pubmed | Peripheral endoplasmic reticulum localization of the Gp78 ubiquitin ligase activity. | 1.39e-05 | 2 | 130 | 2 | 22328510 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28656280 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 1.39e-05 | 2 | 130 | 2 | 21705081 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 10552998 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28441502 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 1.39e-05 | 2 | 130 | 2 | 9196326 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22184139 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18754873 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25540325 | ||
| Pubmed | Isolation and expression of a complementary DNA that confers multidrug resistance. | 1.39e-05 | 2 | 130 | 2 | 3022150 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23583712 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16987818 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 32610136 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 2570420 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 8898203 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 2473069 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28274756 | ||
| Pubmed | The junctional epithelium originates from the odontogenic epithelium of an erupted tooth. | 1.39e-05 | 2 | 130 | 2 | 24785116 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 30361615 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19185004 | ||
| Pubmed | Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. | 1.39e-05 | 2 | 130 | 2 | 14625558 | |
| Pubmed | Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. | 1.39e-05 | 2 | 130 | 2 | 18221379 | |
| Pubmed | Vectors for co-expression of an unrestricted number of proteins. | 1.39e-05 | 2 | 130 | 2 | 17311810 | |
| Pubmed | Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells. | 1.39e-05 | 2 | 130 | 2 | 21745157 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18215618 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 33427061 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 26327335 | ||
| Pubmed | Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. | 1.39e-05 | 2 | 130 | 2 | 28017939 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19121371 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19781771 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12861009 | ||
| Pubmed | What have we learnt thus far from mice with disrupted P-glycoprotein genes? | 1.39e-05 | 2 | 130 | 2 | 8763339 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24277524 | ||
| Pubmed | The ATPase VCP/p97 functions as a disaggregase against toxic Huntingtin-exon1 aggregates. | 1.39e-05 | 2 | 130 | 2 | 30069866 | |
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 1.39e-05 | 2 | 130 | 2 | 9473291 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 37431882 | ||
| Pubmed | Lysophosphatidic acid signaling may initiate fetal hydrocephalus. | 1.39e-05 | 2 | 130 | 2 | 21900594 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 2471060 | ||
| Pubmed | NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation. | 1.39e-05 | 2 | 130 | 2 | 31664505 | |
| Pubmed | Cul4A Modulates Invasion and Metastasis of Lung Cancer Through Regulation of ANXA10. | 1.39e-05 | 2 | 130 | 2 | 31052599 | |
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 1.39e-05 | 2 | 130 | 2 | 18231753 | |
| Pubmed | PLP2/A4 interacts with CCR1 and stimulates migration of CCR1-expressing HOS cells. | 1.39e-05 | 2 | 130 | 2 | 15474493 | |
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 1.39e-05 | 2 | 130 | 2 | 32058310 | |
| Pubmed | Y2 and Y4 receptor signaling synergistically act on energy expenditure and physical activity. | 1.39e-05 | 2 | 130 | 2 | 20881101 | |
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 1.39e-05 | 2 | 130 | 2 | 17196930 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24804815 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 3768958 | ||
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 1.39e-05 | 2 | 130 | 2 | 38522903 | |
| Pubmed | Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. | 1.39e-05 | 2 | 130 | 2 | 15195086 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24368600 | ||
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 1.39e-05 | 2 | 130 | 2 | 3477522 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16857572 | ||
| Pubmed | Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice. | 1.39e-05 | 2 | 130 | 2 | 16364461 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 1969609 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24140176 | ||
| Pubmed | Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. | 1.39e-05 | 2 | 130 | 2 | 9419367 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 2248681 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17496233 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 26586297 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17440929 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 7832992 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16216428 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 11826402 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9804623 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18703779 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12215548 | ||
| Pubmed | Modulation of LPA receptor expression in the human brain following neurotrauma. | 1.39e-05 | 2 | 130 | 2 | 21234797 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 10453001 | ||
| Pubmed | RALGAPA1 KIF1A WDR7 VPS45 VPS13C NBEA TSC2 CEMIP2 SLC12A4 VPS13A | 2.11e-05 | 504 | 130 | 10 | 34432599 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CUL4A RALGAPA1 AARS1 HIPK4 CLASP1 NTRK3 TSC2 ECT2 CCDC88C C2CD3 NF1 PROSER2 DEPDC1B | 2.19e-05 | 861 | 130 | 13 | 36931259 |
| Pubmed | 2.24e-05 | 150 | 130 | 6 | 32423001 | ||
| Pubmed | 2.39e-05 | 407 | 130 | 9 | 12693553 | ||
| Pubmed | Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. | 4.15e-05 | 3 | 130 | 2 | 7814632 | |
| Pubmed | Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling. | 4.15e-05 | 3 | 130 | 2 | 22015657 | |
| Pubmed | VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. | 4.15e-05 | 3 | 130 | 2 | 30093493 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 9778357 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 24192121 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 31189171 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 16504475 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 24820123 | ||
| Pubmed | Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor. | 4.15e-05 | 3 | 130 | 2 | 23569130 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 8547326 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 12123830 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 19899077 | ||
| Pubmed | Y2 and Y4 receptor signalling attenuates the skeletal response of central NPY. | 4.15e-05 | 3 | 130 | 2 | 20635164 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 28533432 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 11093753 | ||
| Interaction | RHOB interactions | RALGAPA1 FAM234A EPPK1 DSC3 KIF26A VPS45 NBEA TSC2 CACHD1 ECT2 CEMIP2 CCDC88C NF1 SLC12A4 VPS13A DLG1 EXOC2 FERMT2 DEPDC1B VCP | 2.29e-07 | 840 | 125 | 20 | int:RHOB |
| Interaction | DIRAS3 interactions | RALGAPA1 VPS45 NBEA CACHD1 HUWE1 CEMIP2 SLC12A4 DLG1 FERMT2 DEPDC1B VCP | 7.30e-07 | 262 | 125 | 11 | int:DIRAS3 |
| Interaction | LAMP3 interactions | RALGAPA1 KIF1A VPS45 VPS13C NBEA TSC2 CEMIP2 ABCB1 SLC12A4 SEL1L3 DLG1 PDS5A FERMT2 DEPDC1B | 1.98e-06 | 486 | 125 | 14 | int:LAMP3 |
| Interaction | RHOQ interactions | RALGAPA1 DSC3 WDR7 VPS13C CACHD1 CEMIP2 ABCB1 NF1 SLC12A4 VPS13A DLG1 FERMT2 DEPDC1B | 3.76e-06 | 442 | 125 | 13 | int:RHOQ |
| Interaction | HRAS interactions | CUL4A RALGAPA1 FAM234A DSC3 VPS45 NTRK3 CACHD1 CEMIP2 NF1 SLC12A4 DLG1 PDS5A CCR1 IL1RL1 FERMT2 DEPDC1B | 1.08e-05 | 725 | 125 | 16 | int:HRAS |
| Interaction | HMGCR interactions | 1.59e-05 | 129 | 125 | 7 | int:HMGCR | |
| Interaction | ANXA10 interactions | 1.90e-05 | 9 | 125 | 3 | int:ANXA10 | |
| Interaction | RAB9A interactions | CUL4A RALGAPA1 KIF1A WDR7 VPS45 VPS13C NBEA TSC2 CEMIP2 VPS13A DLG1 FERMT2 DEPDC1B HTT | 1.98e-05 | 595 | 125 | 14 | int:RAB9A |
| Interaction | EPPK1 interactions | 2.38e-05 | 189 | 125 | 8 | int:EPPK1 | |
| Interaction | LYPD3 interactions | 2.83e-05 | 141 | 125 | 7 | int:LYPD3 | |
| Interaction | LAMTOR1 interactions | CUL4A DSC3 KIF1A WDR7 VPS45 VPS13C NBEA TSC2 CACHD1 CEMIP2 SLC12A4 DLG1 FERMT2 DEPDC1B HTT | 4.17e-05 | 722 | 125 | 15 | int:LAMTOR1 |
| Interaction | RAB11A interactions | RALGAPA1 WDR7 VPS45 VPS13C NBEA CACHD1 CEMIP2 ABCB1 SLC12A4 VPS13A DLG1 EXOC2 FERMT2 DEPDC1B VCP HTT | 5.56e-05 | 830 | 125 | 16 | int:RAB11A |
| Interaction | RAB5C interactions | CUL4A WDR7 VPS45 VPS13C HUWE1 ECT2 CEMIP2 SLC12A4 VPS13A DLG1 FERMT2 DEPDC1B VCP | 9.20e-05 | 600 | 125 | 13 | int:RAB5C |
| Interaction | TNFSF13B interactions | 9.89e-05 | 119 | 125 | 6 | int:TNFSF13B | |
| Interaction | ENTREP3 interactions | 1.04e-04 | 120 | 125 | 6 | int:ENTREP3 | |
| Interaction | LAMP2 interactions | RALGAPA1 KIF1A WDR7 VPS45 VPS13C NBEA TSC2 SLC12A4 DLG1 FERMT2 DEPDC1B VCP HTT | 1.07e-04 | 609 | 125 | 13 | int:LAMP2 |
| Interaction | CIDEC interactions | 1.23e-04 | 16 | 125 | 3 | int:CIDEC | |
| Interaction | RAB5A interactions | PRPSAP1 WDR7 VPS45 TSC2 CACHD1 CEMIP2 CCDC88C SLC12A4 DLG1 CCR1 FERMT2 DEPDC1B DYNC1H1 HTT | 1.25e-04 | 706 | 125 | 14 | int:RAB5A |
| Interaction | RAB4A interactions | RALGAPA1 WDR7 VPS45 VPS13C NBEA CACHD1 CEMIP2 SLC12A4 VPS13A DEPDC1B HTT | 1.32e-04 | 457 | 125 | 11 | int:RAB4A |
| GeneFamily | ATP binding cassette subfamily B | 5.56e-10 | 11 | 77 | 5 | 806 | |
| GeneFamily | Lysophosphatidic acid receptors | 2.66e-04 | 6 | 77 | 2 | 205 | |
| GeneFamily | CD molecules|Integrin beta subunits | 6.32e-04 | 9 | 77 | 2 | 1159 | |
| GeneFamily | Neuropeptide receptors | 7.88e-04 | 10 | 77 | 2 | 854 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 3.24e-03 | 20 | 77 | 2 | 433 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 6.92e-06 | 200 | 129 | 8 | M6208 | |
| ToppCell | ILEUM-inflamed-(6)_ILC1|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.01e-07 | 194 | 129 | 8 | dc9ca407ec3ebec1a3dea1213a2beef28c1dc043 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-07 | 172 | 129 | 7 | 6379ae0aca9007c3a8a87e3330908fc90961ad3f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 195 | 129 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 195 | 129 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.83e-06 | 198 | 129 | 7 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.83e-06 | 198 | 129 | 7 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-06 | 135 | 129 | 6 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | severe-CD4+_T_naive|World / disease stage, cell group and cell class | 6.55e-06 | 157 | 129 | 6 | ccf9abe0b59e9ea728cec4bba1872ffe14c7385c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.04e-06 | 159 | 129 | 6 | 1dde4d19cc0fde7ebbccb4c31bb845a92206021b | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-06 | 160 | 129 | 6 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 9.32e-06 | 167 | 129 | 6 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.65e-06 | 168 | 129 | 6 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.98e-06 | 169 | 129 | 6 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-05 | 171 | 129 | 6 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.26e-05 | 176 | 129 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.30e-05 | 177 | 129 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 177 | 129 | 6 | fd4a297e519b3959811a462d63feebff76429031 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 177 | 129 | 6 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 177 | 129 | 6 | e995230ef207dcd87eab4550617589016ffa9970 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.38e-05 | 179 | 129 | 6 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-05 | 182 | 129 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-05 | 183 | 129 | 6 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.83e-05 | 188 | 129 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 189 | 129 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 189 | 129 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-05 | 192 | 129 | 6 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 196 | 129 | 6 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.31e-05 | 196 | 129 | 6 | 8a3a63129adfbe58558af91336f81d397c291ed0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-05 | 196 | 129 | 6 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-05 | 196 | 129 | 6 | 1cc2b11764584129703ec61965e8ec4e051464e7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 196 | 129 | 6 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.44e-05 | 198 | 129 | 6 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.44e-05 | 198 | 129 | 6 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | COVID-19_Severe-NK|COVID-19_Severe / disease group, cell group and cell class | 2.44e-05 | 198 | 129 | 6 | 0cb88084eac25604ec8f9b1497fb8d2433f1971c | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.71e-05 | 129 | 129 | 5 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-05 | 135 | 129 | 5 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-05 | 140 | 129 | 5 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.67e-05 | 141 | 129 | 5 | d3ce2218bfa9750795d920e1ef162ea44efb2e66 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.67e-05 | 141 | 129 | 5 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.67e-05 | 141 | 129 | 5 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Tmem2_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.20e-05 | 79 | 129 | 4 | cd182dbc8d0ccc2406e78c9ba71476c1f463359b | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Tmem2_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.20e-05 | 79 | 129 | 4 | bcb9181d7de7a385b890523299f8290836aa536e | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.88e-05 | 155 | 129 | 5 | 4ae91bc7dbb9f713a1f110c17834b1d89f1b28db | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.88e-05 | 155 | 129 | 5 | fdcc8a475156329b3594d5ed22ba03538305327c | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.88e-05 | 155 | 129 | 5 | 1fb49b48e34e740118908951e079ea2a9994ae4f | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.88e-05 | 155 | 129 | 5 | b5d5c38b269e9318970fcce564df1c8ed7a7ccc6 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 160 | 129 | 5 | 9f1fec2cf565193c73cc3c8a4f0476e57478e3b8 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.09e-04 | 85 | 129 | 4 | 159b3ac93490c3e4918ea61f8ede7add9e63ca40 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-04 | 162 | 129 | 5 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 162 | 129 | 5 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 163 | 129 | 5 | f558ad9569e5137e62a601ba4f073e69ed8f8650 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.16e-04 | 164 | 129 | 5 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-04 | 166 | 129 | 5 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 166 | 129 | 5 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 166 | 129 | 5 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 167 | 129 | 5 | 713899690e4acd9d259645e363c26983d6ef3022 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 167 | 129 | 5 | d30b96c39da3dd02500443877a4eb3500e26802c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 169 | 129 | 5 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 169 | 129 | 5 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 169 | 129 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 170 | 129 | 5 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 172 | 129 | 5 | d40a8bd61114b49a5837c836136a13c37c8f7de0 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Sln_(Unipolar_brush_cell)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.48e-04 | 92 | 129 | 4 | a5b89f971b904b8e280fe66996a7f8efd92c2132 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Sln_(Unipolar_brush_cell)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.48e-04 | 92 | 129 | 4 | b867cd7923585b13beaf086c40781bab2d7b7434 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 173 | 129 | 5 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 173 | 129 | 5 | 62abaaaf48cabd1423f17fb27c33b75ea88867f4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 173 | 129 | 5 | 09cd878c33534bd476d6a4880f5582076189da8c | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 174 | 129 | 5 | 7565f6d1c743809807d248ab0e098a2474d9c5b9 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.65e-04 | 177 | 129 | 5 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.65e-04 | 177 | 129 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class (2021.01.30) | 1.70e-04 | 178 | 129 | 5 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 182 | 129 | 5 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 182 | 129 | 5 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 182 | 129 | 5 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 182 | 129 | 5 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 183 | 129 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 183 | 129 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 185 | 129 | 5 | 60206c7322b4ddb2010040aac70561df842c9843 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 185 | 129 | 5 | 110d5f02759c8235b14aea524ea47199696094ea | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 2.03e-04 | 185 | 129 | 5 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.08e-04 | 186 | 129 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-04 | 186 | 129 | 5 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 187 | 129 | 5 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 187 | 129 | 5 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Early_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.19e-04 | 188 | 129 | 5 | 6151051c027c7ff7d5d4bf5f1e11d7fe58eb22ed | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.19e-04 | 188 | 129 | 5 | a29c43a91ed1364a09d5abab6efa51b8061bce74 | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.19e-04 | 188 | 129 | 5 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 189 | 129 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | (2)_Fibroblasts-(22)_Fibro-3|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.30e-04 | 190 | 129 | 5 | 3aed03b87ba2c8d479048c3ceef3ff5e38746c28 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 190 | 129 | 5 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 190 | 129 | 5 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.35e-04 | 191 | 129 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 191 | 129 | 5 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.35e-04 | 191 | 129 | 5 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.35e-04 | 191 | 129 | 5 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.35e-04 | 191 | 129 | 5 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 2.41e-04 | 192 | 129 | 5 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 192 | 129 | 5 | 2f539653a20006bef814e6b4acd1023d6fdad5c6 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.41e-04 | 192 | 129 | 5 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 2.41e-04 | 192 | 129 | 5 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| Drug | AC1L2MCS | 1.64e-06 | 5 | 126 | 3 | CID000023441 | |
| Drug | AC1L99H3 | 3.27e-06 | 6 | 126 | 3 | CID000440540 | |
| Drug | v 104 | 3.27e-06 | 6 | 126 | 3 | CID000107262 | |
| Drug | tBCEU | 9.08e-06 | 8 | 126 | 3 | CID000164059 | |
| Drug | nicotine glucuronide | 9.08e-06 | 8 | 126 | 3 | CID003035848 | |
| Drug | iodoarylazidoprazosin | 9.08e-06 | 8 | 126 | 3 | CID000115344 | |
| Drug | tXMP | 9.08e-06 | 8 | 126 | 3 | CID003081384 | |
| Drug | AC1L1G85 | 1.22e-05 | 54 | 126 | 5 | CID000003569 | |
| Drug | NSC648766 | 1.31e-05 | 93 | 126 | 6 | CID000003199 | |
| Drug | So324 | 1.36e-05 | 9 | 126 | 3 | CID000462261 | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.38e-05 | 196 | 126 | 8 | 4723_DN | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; HL60; HG-U133A | 1.60e-05 | 200 | 126 | 8 | 2044_UP | |
| Drug | AC1MZ4R5 | 1.93e-05 | 10 | 126 | 3 | CID003842392 | |
| Drug | Emd 51921 | 1.93e-05 | 10 | 126 | 3 | CID000164353 | |
| Drug | diC4PC | 1.93e-05 | 10 | 126 | 3 | CID000193375 | |
| Drug | mesochlorin e6 monoethylenediamine | 3.04e-05 | 2 | 126 | 2 | CID005488855 | |
| Drug | taxuspine C | 3.04e-05 | 2 | 126 | 2 | CID005321745 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 3.04e-05 | 2 | 126 | 2 | CID000283230 | |
| Drug | Ro44-5912 | 3.04e-05 | 2 | 126 | 2 | CID000197370 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 3.04e-05 | 2 | 126 | 2 | CID005281903 | |
| Drug | AC1L8LCS | 3.04e-05 | 2 | 126 | 2 | CID000383419 | |
| Drug | sulfurmycin A | 3.04e-05 | 2 | 126 | 2 | CID000155836 | |
| Drug | 1,9-dideoxyforskolin | 3.04e-05 | 2 | 126 | 2 | ctd:C047983 | |
| Drug | DAPDOX | 3.04e-05 | 2 | 126 | 2 | CID000164413 | |
| Drug | AC1Q6JJG | 3.04e-05 | 2 | 126 | 2 | CID000164322 | |
| Drug | YM212 | 3.04e-05 | 2 | 126 | 2 | CID000129980 | |
| Drug | Ro11-2933 | 3.04e-05 | 2 | 126 | 2 | CID000115215 | |
| Drug | cnidiadin | 3.04e-05 | 2 | 126 | 2 | CID005315980 | |
| Drug | conferone | 3.04e-05 | 2 | 126 | 2 | CID001757335 | |
| Drug | NSC330500 | 3.04e-05 | 2 | 126 | 2 | CID000433448 | |
| Drug | VX-710-3 | 3.04e-05 | 2 | 126 | 2 | CID006450549 | |
| Drug | NAc-LLY-amide | 3.04e-05 | 2 | 126 | 2 | CID000443109 | |
| Drug | 62820-12-6 | 3.04e-05 | 2 | 126 | 2 | CID006449905 | |
| Drug | IC-1 | 3.51e-05 | 12 | 126 | 3 | CID000049829 | |
| Drug | AC1L1AUV | 4.55e-05 | 13 | 126 | 3 | CID000051323 | |
| Drug | I mAb | 4.55e-05 | 13 | 126 | 3 | CID003082777 | |
| Drug | fodipir | 4.59e-05 | 36 | 126 | 4 | CID000060683 | |
| Drug | a-factor | 5.33e-05 | 73 | 126 | 5 | CID000119102 | |
| Drug | AD 288 | 5.76e-05 | 14 | 126 | 3 | CID000073553 | |
| Drug | robinetin | 5.76e-05 | 14 | 126 | 3 | CID005281692 | |
| Drug | NSC 284682 | 8.79e-05 | 16 | 126 | 3 | CID000072518 | |
| Drug | 2-chloroquinazoline | 9.08e-05 | 3 | 126 | 2 | CID000074054 | |
| Drug | fluoroanilinoazatoxin | 9.08e-05 | 3 | 126 | 2 | CID000378896 | |
| Drug | Dihydrocyclosporin C | 9.08e-05 | 3 | 126 | 2 | CID000196411 | |
| Drug | NSC82591 | 9.08e-05 | 3 | 126 | 2 | CID000579054 | |
| Drug | CID5317124 | 9.08e-05 | 3 | 126 | 2 | CID005317124 | |
| Drug | NSC688503 | 9.08e-05 | 3 | 126 | 2 | CID000390744 | |
| Drug | Cp-100356 | 9.08e-05 | 3 | 126 | 2 | CID000196918 | |
| Drug | BIBW22BS | 9.08e-05 | 3 | 126 | 2 | CID000132088 | |
| Drug | AC1NSGRQ | 9.08e-05 | 3 | 126 | 2 | CID005333904 | |
| Drug | Technetium Tc 99m Sestamibi | 9.08e-05 | 3 | 126 | 2 | ctd:D017256 | |
| Drug | taxinine | 9.08e-05 | 3 | 126 | 2 | CID005321702 | |
| Drug | Hapalosin | 9.08e-05 | 3 | 126 | 2 | CID000133055 | |
| Drug | haemanthidine | 9.08e-05 | 3 | 126 | 2 | CID000124066 | |
| Drug | taccalonolide A | 9.08e-05 | 3 | 126 | 2 | CID000441685 | |
| Drug | taccalonolide E | 9.08e-05 | 3 | 126 | 2 | CID005321583 | |
| Drug | iodomycin | 9.08e-05 | 3 | 126 | 2 | CID000149155 | |
| Drug | R101933 | 9.08e-05 | 3 | 126 | 2 | CID000219080 | |
| Drug | methylazatoxin | 9.08e-05 | 3 | 126 | 2 | CID000148162 | |
| Drug | dendroamide A | 9.08e-05 | 3 | 126 | 2 | CID000177307 | |
| Drug | Wp159 | 9.08e-05 | 3 | 126 | 2 | CID003060549 | |
| Drug | AC1L2Z11 | 9.08e-05 | 3 | 126 | 2 | CID000080228 | |
| Drug | NK-250 | 9.08e-05 | 3 | 126 | 2 | CID000164220 | |
| Drug | 5-N-acetylardeemin | 9.08e-05 | 3 | 126 | 2 | CID000127303 | |
| Drug | 1-bromo-4-chlorobutane | 9.08e-05 | 3 | 126 | 2 | CID000081364 | |
| Drug | D-Val-Thz | 9.08e-05 | 3 | 126 | 2 | CID003082826 | |
| Drug | AC1L87CG | 9.08e-05 | 3 | 126 | 2 | CID000373763 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 9.23e-05 | 190 | 126 | 7 | 6199_UP | |
| Drug | fisetin; Up 200; 50uM; PC3; HG-U133A | 9.54e-05 | 191 | 126 | 7 | 579_UP | |
| Drug | rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.02e-04 | 193 | 126 | 7 | 921_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 193 | 126 | 7 | 3627_DN | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 194 | 126 | 7 | 4422_DN | |
| Drug | Pgh1 | 1.06e-04 | 17 | 126 | 3 | CID005283048 | |
| Drug | 8-azido-ADP | 1.06e-04 | 17 | 126 | 3 | CID000121934 | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 1.09e-04 | 195 | 126 | 7 | 6074_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 1.09e-04 | 195 | 126 | 7 | 6739_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.12e-04 | 196 | 126 | 7 | 7338_UP | |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.12e-04 | 196 | 126 | 7 | 3871_UP | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.12e-04 | 196 | 126 | 7 | 7333_UP | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 196 | 126 | 7 | 3331_UP | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 197 | 126 | 7 | 6099_UP | |
| Drug | LY294002; Down 200; 10uM; PC3; HG-U133A | 1.16e-04 | 197 | 126 | 7 | 429_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 197 | 126 | 7 | 3940_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.16e-04 | 197 | 126 | 7 | 7514_UP | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; HL60; HT_HG-U133A | 1.19e-04 | 198 | 126 | 7 | 2140_DN | |
| Drug | Ebselen [60940-34-3]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.19e-04 | 198 | 126 | 7 | 5778_UP | |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; HL60; HG-U133A | 1.19e-04 | 198 | 126 | 7 | 2030_UP | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.19e-04 | 198 | 126 | 7 | 7556_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; HL60; HG-U133A | 1.23e-04 | 199 | 126 | 7 | 1970_UP | |
| Drug | 3-aminobenzamide; Down 200; 10000uM; MCF7; HG-U133A | 1.23e-04 | 199 | 126 | 7 | 590_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.23e-04 | 199 | 126 | 7 | 7274_DN | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; HL60; HG-U133A | 1.27e-04 | 200 | 126 | 7 | 1980_UP | |
| Drug | AC1L3X8G | 1.27e-04 | 18 | 126 | 3 | CID000123753 | |
| Drug | talinolol | 1.27e-04 | 18 | 126 | 3 | CID000068770 | |
| Drug | Basifungin | 1.27e-04 | 18 | 126 | 3 | CID000072050 | |
| Drug | celiprolol | 1.33e-04 | 47 | 126 | 4 | CID000002663 | |
| Drug | avermectin | 1.44e-04 | 48 | 126 | 4 | CID006450460 | |
| Drug | moxidectin | 1.50e-04 | 19 | 126 | 3 | CID009571036 | |
| Drug | eupatin | 1.81e-04 | 4 | 126 | 2 | CID005317287 | |
| Drug | dimethylaminobenzoate | 1.81e-04 | 4 | 126 | 2 | CID012241998 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 4.19e-06 | 8 | 126 | 3 | DOID:0050753 (implicated_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 6.27e-06 | 9 | 126 | 3 | DOID:1485 (implicated_via_orthology) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 1.81e-05 | 2 | 126 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 1.81e-05 | 2 | 126 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Fibrosarcoma | 5.41e-05 | 3 | 126 | 2 | C0016057 | |
| Disease | Acute Myeloid Leukemia, M1 | 2.04e-04 | 125 | 126 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.04e-04 | 125 | 126 | 5 | C1879321 | |
| Disease | liposarcoma | 2.68e-04 | 6 | 126 | 2 | C0023827 | |
| Disease | Cystic kidney | 2.68e-04 | 6 | 126 | 2 | C0022679 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 3.75e-04 | 7 | 126 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | peripheral neuropathy | 3.75e-04 | 7 | 126 | 2 | EFO_0003100 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.82e-04 | 239 | 126 | 6 | EFO_0010934 | |
| Disease | gallbladder neoplasm | 6.39e-04 | 9 | 126 | 2 | EFO_0004606 | |
| Disease | Mood Disorders | 7.90e-04 | 168 | 126 | 5 | C0525045 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 7.96e-04 | 10 | 126 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Congenital Heart Defects | 8.86e-04 | 44 | 126 | 3 | C0018798 | |
| Disease | Leukemia, Myelocytic, Acute | 9.01e-04 | 173 | 126 | 5 | C0023467 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 9.70e-04 | 11 | 126 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | Cystic Kidney Diseases | 9.70e-04 | 11 | 126 | 2 | C1691228 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 1.01e-03 | 46 | 126 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Hematologic Neoplasms | 1.16e-03 | 12 | 126 | 2 | C0376545 | |
| Disease | cholestasis (biomarker_via_orthology) | 1.21e-03 | 49 | 126 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Medulloblastoma | 1.29e-03 | 50 | 126 | 3 | C0025149 | |
| Disease | Squamous cell carcinoma of the head and neck | 1.44e-03 | 52 | 126 | 3 | C1168401 | |
| Disease | antisaccade response measurement | 1.79e-03 | 56 | 126 | 3 | EFO_0006874 | |
| Disease | obsolete_red blood cell distribution width | CUL4A PRPSAP1 FAM234A CLASP1 ABCB6 HEXD ECT2 ABCB1 ABCB4 CLCN6 MUC17 VPS13A HELZ2 PDS5A | 1.87e-03 | 1347 | 126 | 14 | EFO_0005192 |
| Disease | Intrahepatic cholestasis of pregnancy | 2.09e-03 | 16 | 126 | 2 | EFO_0009048 | |
| Disease | mean reticulocyte volume | CUL4A CLASP1 ABCB4 CLCN6 NYNRIN GALNT9 VPS13A HELZ2 ATM CDK6 | 2.30e-03 | 799 | 126 | 10 | EFO_0010701 |
| Disease | Charcot-Marie-Tooth disease type 2 | 2.36e-03 | 17 | 126 | 2 | cv:C0270914 | |
| Disease | blood metabolite measurement | 2.95e-03 | 19 | 126 | 2 | EFO_0005664 | |
| Disease | Cholecystitis | 2.95e-03 | 19 | 126 | 2 | HP_0001082 | |
| Disease | colorectal cancer, inflammatory bowel disease | 2.95e-03 | 19 | 126 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | Bladder Neoplasm | 3.11e-03 | 140 | 126 | 4 | C0005695 | |
| Disease | Intellectual Disability | 3.15e-03 | 447 | 126 | 7 | C3714756 | |
| Disease | Malignant neoplasm of urinary bladder | 3.19e-03 | 141 | 126 | 4 | C0005684 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 3.27e-03 | 20 | 126 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Arthrogryposis | 3.60e-03 | 21 | 126 | 2 | C0003886 | |
| Disease | cytotoxicity measurement, response to metformin | 3.60e-03 | 21 | 126 | 2 | EFO_0006952, GO_1901558 | |
| Disease | photoreceptor cell layer thickness measurement | 3.79e-03 | 148 | 126 | 4 | EFO_0803370 | |
| Disease | basophil count, eosinophil count | 3.82e-03 | 241 | 126 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.17e-03 | 152 | 126 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | monocyte percentage of leukocytes | 4.22e-03 | 731 | 126 | 9 | EFO_0007989 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTFTRIVTLIEHQRI | 391 | Q86Y25 | |
| RVLLELANVSTHIVA | 466 | Q9H0X4 | |
| RTLEAVRHVGVAIVS | 1281 | Q9P2K9 | |
| HNKTVIRILIARSEI | 266 | Q9UJ72 | |
| TNVELVTRTRTEHLS | 271 | Q6ZTN6 | |
| SVTAVTIHRLSEEQR | 381 | Q7Z407 | |
| TIHRLSEEQRVQVTS | 386 | Q7Z407 | |
| TIVVAHRLSTIRSAD | 576 | Q2M3G0 | |
| RIISVNSVDLRAASH | 511 | Q12959 | |
| RLVETHATRVIALIN | 371 | P51693 | |
| IISNTRFIAAVIERH | 1161 | Q5VU97 | |
| RTTIVVAHRLSTVVN | 776 | Q9NP58 | |
| TSIEERVAHLRRVQI | 401 | Q8WUY9 | |
| LSTIREVAVLRHLET | 56 | Q00534 | |
| VTITVRLIRSFEHRN | 6 | Q3KRA6 | |
| RSIRIINTLTSQEHT | 136 | Q6P9G0 | |
| DIDQILLRRTHTITI | 1486 | Q9P2D1 | |
| TLLAIAHRQLVEVVR | 651 | Q149M9 | |
| IRHDVIVTIITAAKR | 376 | Q29RF7 | |
| SQLRVHRLTATSAEI | 886 | O95153 | |
| LSSHRSLVQRVETIS | 666 | Q9H8V3 | |
| VSTITLTVIALDRHR | 136 | P49146 | |
| TTIVIAHRLSTVRNA | 581 | P08183 | |
| LAVHAQIVSTLTRAS | 191 | Q7L1V2 | |
| RLIASTAIVLTVLHS | 1131 | Q9NRD9 | |
| VLILTAIISSTRLHT | 41 | Q8NGN7 | |
| VATLLAIAVERHRSV | 116 | Q9HBW0 | |
| VLSASRREVLVDHVV | 251 | Q969S2 | |
| INITDISRNITSIHI | 71 | Q16288 | |
| TVSILSLVLVALERH | 126 | P50391 | |
| RHIRTVTLQVLTALA | 111 | Q8NE63 | |
| NEALSVILRSVHSVV | 161 | Q9HCQ5 | |
| RIGSVTISDVLEIHR | 281 | Q9BVA6 | |
| HTRMSNRRVVVVIVV | 156 | Q92633 | |
| TVHARTLTTLREDLV | 901 | Q9P219 | |
| AIQTVRLTHESLTAL | 551 | Q96KP1 | |
| RRSSTVRIHVTVLDT | 221 | Q9Y5G4 | |
| RTIVFELLTRHNLIS | 181 | Q01064 | |
| LALVTQVSLHLRSSV | 366 | Q8WVB3 | |
| ETLSTVQLAARIHRL | 711 | Q9ULI4 | |
| LRHTFVRQVVSVILA | 341 | Q6W3E5 | |
| QIRVVHRDGRVITLS | 501 | Q9NVC6 | |
| NVTRTRIVLADVKVH | 196 | Q9NRX1 | |
| LLDVTHSELTVTVRV | 1351 | O15230 | |
| ARLIASVSQDLVHVV | 511 | Q9C091 | |
| ASLRTLTSIVHLERT | 326 | Q7Z6Z7 | |
| SLTRHVTQEFVSRTL | 1791 | P16144 | |
| ETTVLAAVLRHISVL | 266 | Q9Y3T9 | |
| LITSIVVLVERGNHS | 96 | Q04941 | |
| STISRNITVHLVELL | 436 | Q7Z442 | |
| HALLVRLQEVTHSVR | 176 | P26010 | |
| DALVRHTSLVTQLVS | 71 | Q5TIA1 | |
| GRTTIVIAHRLSTVR | 581 | P21439 | |
| VIAHRLSTVRNADVI | 586 | P21439 | |
| RIEVSHALGLTERQV | 176 | P17481 | |
| ALVENEIAVLRRISH | 56 | Q6P2M8 | |
| IIVTTSNNHIEVRAE | 96 | Q9UBY9 | |
| DVHRVLVARIIHAVT | 181 | Q13315 | |
| TRIQSLVSILRTTVH | 616 | P51797 | |
| NLSRVIAAVSHELIT | 1001 | P42858 | |
| VTAVETNIRKSRRHI | 431 | Q01638 | |
| TTSEAIQDVIRHIRV | 371 | P51553 | |
| VTIRRADGSLVHISI | 571 | Q9P2H3 | |
| VLAARTVSISVQIIR | 1191 | Q4AC94 | |
| TALNRALVTVHVRDL | 451 | Q14574 | |
| SHVTIRRTVLEEIGN | 26 | O95067 | |
| SRHLDLAVQVTEVIA | 276 | P32246 | |
| QILQRRTHTITIQSE | 981 | Q8TD26 | |
| RHVTRVLVKDTAVQT | 521 | Q9H6X5 | |
| IALVQEVRDSHLTAV | 56 | P24855 | |
| LHEAVRAVQSSTSIR | 66 | Q13619 | |
| SILGSIRIRVSHTEV | 21 | J3KSC0 | |
| VNEALSVILRSVHSA | 161 | Q6IS24 | |
| VELARRNRIVVLTIH | 236 | Q9H222 | |
| LRLTSDATVHSIVIQ | 141 | Q9UHN6 | |
| LITELVHQRDVTRSL | 1811 | Q14204 | |
| VDISLILSEAIRRIH | 326 | Q14558 | |
| IIATEIRNHSQISRV | 466 | P55286 | |
| TALLHRIVRQVTSDV | 411 | Q5W0V3 | |
| SVHVTDLNRDVTLRV | 21 | Q96AC1 | |
| VHVVVSAVRELNRSQ | 311 | Q16478 | |
| AELARHRVVVTTTSQ | 636 | Q9BYK8 | |
| HRVVVTTTSQARELR | 641 | Q9BYK8 | |
| LLVVVKSVITQHDRR | 136 | Q8NFL0 | |
| ITGRHLDTLRVVAQE | 36 | Q96LJ7 | |
| TVERLRSRVVHKQVV | 491 | Q9C0B2 | |
| QGIQRRITVTLLHET | 1171 | Q12756 | |
| EIRILQSHISDTSVV | 251 | P78385 | |
| RLEVTVSHVALTAIL | 1161 | Q9P2P1 | |
| RTVLVIAHRLSTVRG | 661 | Q9NUT2 | |
| VIRVATQISLSVHLV | 461 | Q5HYA8 | |
| ITQAVLRIKSVEARH | 221 | Q8NGZ4 | |
| RLGSVVVEHDVLLRT | 4241 | Q685J3 | |
| STIVHAVQRIAERVK | 106 | P49247 | |
| LTLTREQTERLSHQI | 421 | O75298 | |
| EQTERLSHQITSRVV | 426 | O75298 | |
| VNRVAVHIRVLASLT | 126 | Q9BZD2 | |
| FIRHSISVSAVIVRA | 161 | Q68CR1 | |
| LQTAIHRVTLAQTAV | 311 | Q969S9 | |
| EVQRRHSLVSFVVRI | 141 | Q9BUD6 | |
| VSVQERRAQVLATIH | 276 | Q86WR7 | |
| SFQVDSTVLREVLVH | 986 | Q9NTG1 | |
| SSRVHITRAVLEQFL | 561 | Q8NFP9 | |
| HTRRALQTVAQLILE | 2146 | P58107 | |
| LDSVLTTHERVVQIS | 146 | Q96GC5 | |
| LVVAVNRNDIIHRTV | 281 | Q86YJ6 | |
| VSRVVHNILTQLERT | 61 | Q9HB58 | |
| HLVLVVNTLRRIQAS | 66 | Q9UHV2 | |
| VHTVDQVLSEVSRVL | 151 | P0DPD7 | |
| NEVIVTRSHDARLVL | 1026 | Q9UP95 | |
| VEVELLAHTRRVVSR | 121 | Q9UL12 | |
| LVLERRVHFLQSVVV | 1046 | Q9NRC6 | |
| AESLLVTVRTAHVIL | 221 | Q9UKV5 | |
| LSRHVSVRTSVVTQQ | 16 | Q96AQ7 | |
| ATSGVVAVRLIIRHT | 426 | Q7Z460 | |
| RRHDSITIVVVSRLV | 221 | P37287 | |
| EDVLTIHVQSLVRAR | 256 | Q6ZS11 | |
| AVSLTLTLVLVFERH | 141 | Q5VZI3 | |
| VTAAVVEVHSRALLV | 1376 | Q96RL7 | |
| TVRTRLAQVGLVQTH | 401 | A2A3L6 | |
| LISIAARTVITHLVN | 1501 | Q6GYQ0 | |
| RQTRRVATLVVTFHA | 46 | Q2QL34 | |
| RVLADHARTITVALA | 296 | P49588 | |
| THGEVERRIVSQLLT | 316 | P55072 | |
| ETISIIRLIEQARHA | 1071 | Q12767 | |
| VARTVRILHTLLTLV | 2406 | P21359 | |
| TVSILSLVLVALERH | 126 | P0DQD5 | |
| HVTVVGELSRLVSER | 331 | Q9NRW7 | |
| TEVTTVDLSVHVRRI | 2746 | Q709C8 | |
| SRNDSIIHILVEVTT | 356 | P40238 | |
| ITVITQTESHRQRLL | 271 | Q9HBG4 | |
| VVLRHLSIAVAATDQ | 296 | O43149 | |
| IIRSHRTQEDTVVAL | 166 | Q9Y4E6 | |
| SVSEHVVRSRIQTSL | 981 | P49815 |